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delivered to the heart and the volume of heart receiving the 
dose of 20Gy or more were evaluated. Volume of the 
territory of the coronary arteries receiving the dose of 20Gy 
or more was also assessed. All 10 patients were treated with 
the DIBH technique. 
 
Results: DIBH compared to FB reduced the mean dose 
delivered to the heart (average 4.4 Gy vs. 2.1Gy). The heart 
volume receiving the dose of 20 Gy or more was reduced to 
almost zero (average 0.1% vs 6 %). DIBH allowed to diminish 
to zero the volume of coronary arteries receiving 20Gy or 
more (average of 0% vs. 16.9%). The early treatment 
tolerance was good – no toxicity higher than Grade 1 skin 
toxicity according to RTOG Acute Radiation Morbidity Scoring 
Criteria was observed. 
 
Conclusion: DIBH technique reduces the dose delivered to 
the heart in comparison to FB, thus it may reduce the late 
cardiotoxicity of radiotherapy. In each patient with the left 
breast cancer qualified to postoperative radiotherapy, the 
DIBH technique should be taken into consideration 
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Purpose or Objective: In hypofractionated stereotactic body 
radiotherapy (SBRT) for lung tumors, the interplay effect 
between tumor respiratory motion and multileaf collimator 
(MLC) motion can play an important role in dynamic plans. 
This study was designed to investigate the interplay effect 
for Rapidarc (RA) SBRT lung treatments, using GafChromic 
EBT3 film and a respiratory motion phantom. 
 
Material and Methods: A heterogeneous programmable 
respiratory motion phantom (Quasar, Modus Medical Devices 
Inc.), with a “tumor” (30 mm diameter) inside a cylindrical 
“lung” insert, was used to simulate a breathing motion in the 
superior/inferior direction. Two amplitudes (10 mm, 20 mm) 
and two breath rates (BRs) (period: 6 s, 4 s) were 
investigated. RA plans were created, based on the 4D CT 
scans of the phantom, one for each amplitude and beam 
quality investigated a) 6MV (600 MU/min) and b) 6MV- 
flattening filter free (FFF) (1400 MU/min). All plans were 
optimized to keep the MLC modulation about 200 MU/Gy. The 
internal target volume (ITV) was prescribed a fractionation 
dose of 22.5 Gy, where the planning target volume (5 mm 
margin to ITV) was covered by 67%. Each plan consisted of 
four half arcs, each measured individually. Measurements 
were carried out both in static condition and with motion for 
the two BRs. GafChromic EBT3 film were placed centrally in 
the tumor, and the measurements were compared with 
calculated dose distributions where gamma analysis per field 
was evaluated (Verisoft v.4.0, PTW-Freiburg). 
 
Results: All static measurements were in good agreement 
with the calculated dose, with a mean local gamma (LG) 
passing rate (3%/2mm) above 96,8% (±0,9) for all fields. With 
10 mm motion, the mean LG passing rate (3%/2mm) for all 
fields in one plan was, with period 6 s: 88,4% (±2,4) for 6MV 
and 82% (±3,5) for 6MV-FFF, and with period 4 s: 78% (±12,6) 
for 6MV and 73,9% (±7,7) for 6MV-FFF. Worst case observed 
was with 20 mm motion, period 4 s and 6MV-FFF, with a 
mean LG passing rate (3%/2mm) of 50,7% (±15,2). Only the 
6MV plan with amplitude 10 mm and period 6 s passed a 
typical clinical acceptance criterion of 90% using 3%/3mm LG 
passing rate. 
 
Conclusion: The impact of interplay effect was highest for 
the largest motion amplitude (20 mm), fastest BR (4 s) and 
for the shortest delivery time (6MV-FFF beam). Although the 
results illustrate LG per field, the motion blurring may 
become dosimetrically significant when the fields are 
summarized, particularly for motions above 10 mm. 
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Purpose or Objective: The purpose is to evaluate the intra-
fraction patient movement for SBRT treatments, obtaining a 
reference level in function of the pathology, starting point 
for future improvements. The parameters considered to be 
improved are the settings of these treatments: positioning, 
immobilization devices and maybe patient training. 
 
Material and Methods: Data from 233 SBRT fractions (from 
05/2013 to 09/2015) of 105 patients (SBRT different 
treatments) were studied.  
All patients have internal fiducial markers, and were treated 
with two Varian (clinac 2100C and 2100CD) linear 
accelerators both with Portal Vision AS500 - IAS3, the 
treatment planning system (TPS) was Philips Pinnacle v9.8, 
and the Record and Verify (R&V) was Mosaiq (Elekta). The 
treatment plan was mainly 3DRT.  
The treatment procedure for each fraction was:  
Before each treatment session a new CT was made. All ROIs 
and fiducials were contoured in it. The displacements from 
external CT marks to isocenter were updated according to 
this. 
The patient was positioned on the couch with all the 
immobilization devices needed, and initially aligned with the 
lasers on the CT marks. Then it was moved to the isocenter 
according to the updated physics displacements.  
Two Portal Images (orthogonal, 0º - 90º) were done until their 
position corresponded to the one of the treatment plan. 
Fiducials were used to check the position against the portal 
vision. When the correct position was found, the first 
treatment field is irradiated.  
For each treatment field, a Portal Image was made. It was 
checked with the corresponding RDR, repositioning the 
patient if necessary. Finally the field was irradiated. If the 
movement detected was greater than a half of the PTV 
margin, the 0º and 90º images were performed once again.  
The treatment positions (couch coordinates) for each field 
were obtained from the R&V. The cases were classified 
according to two main categories:  
Reposition in low % number of fractions: No action required 
by now. 
Reposition in high % number of fractions: The immobilization 
devices and positioning of the patient should be checked 
improved. 
 
Results: Position had to be corrected intra-fraction due to 
the PV images in 36 of the 233 fractions (15.4%).  
45 beams needed patient reposition, that means in average 
1.25 repositions for each patient that needed to be 
repositioned.  
These patients were treated with 245 beams (18.4% of the 
treatment beams needed reposition). 
In Average, the movement magnitude (field to field) was 8 
mm (4 movements greater than 3 cm), and the total session 
time was increased in 7´59´´, due to the reposition process. 
 
Conclusion: The three most frequent tumor localizations 
were: lung, abdominal and cranial. With the collected data, 
patient setup must be improved in abdominal pathology.  
 
 
 
There were other pathologies with low number of cases 
(Spinal cord, rectum…), so the study may not be yet 
representative. 
